2000
DOI: 10.1002/(sici)1099-0690(200005)2000:10<1883::aid-ejoc1883>3.0.co;2-q
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthesis of Gabosines A, B, and C, Carba Sugars fromStreptomyces cellulosae

Abstract: The biosynthesis of the gabosines A−C (3−5) was studied by feeding cultures of Streptomyces cellulosae subsp. griseorubiginosus (strain S 1096) with 13C‐labeled precursors. Although the carba sugars are structurally related to shikimic acid, the biosynthetic origin was found to be different to the shikimate pathway. The results revealed that the gabosines are formed via a pentose phosphate pathway by cyclization of a heptulose phosphate intermediate. This intermediate arises from a triose phosphate by successi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
7
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 26 publications
1
7
0
Order By: Relevance
“…2). A similar origin has recently been demonstrated by Zeeck and coworkers for the gabosines A, B, and C from Streptomyces cellulosae 37…”
Section: Biosynthetic Building Blockssupporting
confidence: 80%
“…2). A similar origin has recently been demonstrated by Zeeck and coworkers for the gabosines A, B, and C from Streptomyces cellulosae 37…”
Section: Biosynthetic Building Blockssupporting
confidence: 80%
“…Compared to this strain with its mainly reduced type I polyketides, S. cellulosae ssp. griseorubiginosus (strain S 1013) produces only four compounds but originated from three different biogenetic pools (Scheme ) 10–13. The gabosines D ( 17 ) and E ( 18 ) are derived from intermediates of the sugar pathway, hexacyclinic acid ( 19 ) represents one of the rare polycyclic type I polyketides, and compound 20 is an angustmycin A derivative 14.…”
Section: Introductionmentioning
confidence: 99%
“…The biosynthesis of a diverse array of clinically relevant natural products involves pathways that parallel the initial steps in shikimate biosynthesis (the primary route to aromatic amino acids) 1. These classes of natural products include the ansamycin antibiotics, such as rifamycin,2, 3 ansamitocin,4 and geldanamycin;5 the aminoglycoside antibiotics, such as neomycin,6 kanamycin,7 butirosin,8 and gentamicin;9, 10 and the C 7 ‐cyclitol‐containing compounds, such as acarbose,11, 12 the validamycins,13, 14 the gabosines,15 and the pyralomicins16 (Scheme 1).…”
Section: Introductionmentioning
confidence: 99%